NEW YORK (GenomeWeb) – Improving diagnosis for children with rare diseases is one of the major goals of the recently-founded Children's National Rare Disease Institute (CNRDI) in Washington, DC, and both the structured use of clinical information and targeted genomic testing will likely help with that.

The institute, which was announced last month, is part of Children's National Health System and evolved from its existing Division of Genetics and Metabolism. It plans to focus exclusively on advancing the care and treatment of children and adults with rare genetic diseases.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.